Therapeutic monitoring of drug plasma concentrations and improved clinical outcomes in GIST
Demetri, G.D.
Clinical Advances in Hematology and Oncology H&o 7(2): S6-S7
2009
ISSN/ISBN: 1543-0790 PMID: 19391310 Document Number: 630805
Document emailed within 1 workday
Related Documents
Sjöqvist, F. 1980: The measurement of psychotherapeutic drug concentrations in biological fluids: utility in clinical trials and practice. Overview by drug classes--clinical monitoring of tricyclic antidepressant plasma concentrations Psychopharmacology Bulletin 16(3): 21-25Hossain, M.; Campbell, D.B. 1975: Fenfluramine and methylcellulose in the treatment of obesity: the relationship between plasma drug concentrations and therapeutic efficacy Postgraduate Medical Journal 51(Suppl 1): 178-182
Winkler, M.; Ringe, B.; Baumann, J.; Loss, M.; Wonigeit, K.; Pichlmayr, R. 1994: Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression Clinical Chemistry 40(12): 2247-2253
Mihu, D.; Imre, S.; Vlase, L.; Achim, M.; Cuciureanu, M. 2008: New method for determination of dydrogesterone in human plasma for therapeutic drug monitoring in gynecological disorders Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 112(3): 837-842
Paxton, J.W. 1981: Therapeutic drug monitoring and clinical pharmacokinetics Australian and New Zealand Journal of Medicine 11(5): 558-561
Laux, G.; Baumann, P.; Hiemke, C. 2007: Therapeutic drug monitoring of antidepressants--clinical aspects Journal of Neural Transmission. Supplementum 72: 261-267
Frewin, D.B.; Shaw, D.R.; Bochner, F. 1982: Therapeutic drug monitoring: a survey of sub- and supra-therapeutic serum drug levels in a large teaching hospital New Zealand Medical Journal 95(719): 774-776
Jones, G.R.D. 2007: Reporting units for therapeutic drug monitoring: a correctable source of potential clinical error Medical Journal of Australia 186(8): 420-421
Dixon, R.; Marin, D. 1981: Tricyclic antidepressants: a simplified approach for the routine clinical monitoring of parent drug and metabolites in plasma using HPLC Research Communications in Chemical Pathology and Pharmacology 33(3): 537-545
Steinborn, B.; Galas-Zgorzalewicz, B. 2000: Therapeutic antiepileptic drug monitoring: thirteen years of experience in the Laboratory of Clinical Neuropharmacology in the Chair and Department of Developmental neurology Neurologia i Neurochirurgia Polska 34 Suppl. 1: 49-59
Lunn, P.G.; Austin, S.; Prentice, A.M.; Whitehead, R.G. 1984: The effect of improved nutrition on plasma prolactin concentrations and postpartum infertility in lactating Gambian women American Journal of Clinical Nutrition 39(2): 227-235
Rånby, M.; Bergsdorf, N.; Nilsson, T.; Mellbring, G.; Winblad, B.; Bucht, G. 1986: Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay Clinical Chemistry 32(12): 2160-2165
Kim, M.H.; Cox, C.; Dave, A.; Draper, H.R.; Kabue, M.; Schutze, G.E.; Ahmed, S.; Kazembe, P.N.; Kline, M.W.; Manary, M. 2012: Prompt initiation of ART with therapeutic food is associated with improved outcomes in HIV-infected Malawian children with malnutrition Journal of Acquired Immune Deficiency Syndromes 59(2): 173-176
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Roots, I. 1986: When is determination of drug concentrations in plasma useful or necessary? Der Internist 27(1): 40-52
Hooper, W.D.; Tyrer, J.H.; Eadie, M.J. 1976: Plasma drug concentrations in therapeutics Medical Journal of Australia 1(10): 313-319
Preston, A.M.; Bercovitch, F.B.; Jimenez, B.D.; Rodriguez Orengo, J.F.; Morales, W.Delgado.; Rodriguez, C.A.; Lebron, M.R.; Rivera, C.E. 2002: Plasma homocysteine concentrations in a population of rhesus monkeys (Macaca mulatta): reference ranges and accompanying plasma concentrations of folate and vitamin B12 Contemporary Topics in Laboratory Animal Science 41(1): 28-30
Mo, P.S. 1983: Therapeutic drug monitoring Zhonghua Nei Ke Za Zhi 22(3): 176-180
Shaw, L.M.; Brayman, K.L. 1994: FK-506 therapeutic drug monitoring Clinical Chemistry 40(12): 2207-2208
Soto, J.; Sacristán, J.A. 1992: Plasma concentrations of theophylline in patients with chronic obstructive pulmonary disease. what therapeutic limit should be used? Medicina Clinica 98(10): 398-399